Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| 1 |
Amazon
AMZN
|
$738M |
| 2 |
Booking.com
BKNG
|
$327M |
| 3 |
PepsiCo
PEP
|
$282M |
| 4 |
Netflix
NFLX
|
$263M |
| 5 |
Comcast
CMCSA
|
$251M |
Top Sells
| 1 |
Exxon Mobil
XOM
|
$726M |
| 2 |
Walmart
WMT
|
$352M |
| 3 |
Becton Dickinson
BDX
|
$331M |
| 4 |
GE Aerospace
GE
|
$315M |
| 5 |
NetEase
NTES
|
$307M |
Sector Composition
| 1 | Healthcare | 16.7% |
| 2 | Technology | 14.08% |
| 3 | Consumer Discretionary | 11.09% |
| 4 | Financials | 10.92% |
| 5 | Industrials | 8.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
101
Usana Health Sciences
USNA
$579M
| $168M | 0.18% |
1,961,466
+30,500
| +2% | +$2.62M |
|
102
AbbVie
ABBV
$374B
| $166M | 0.18% |
+1,755,656
| New | +$166M |
|
103
Regeneron Pharmaceuticals
REGN
$59.8B
| $166M | 0.18% |
482,470
-97,092
| -17% | -$33.4M |
|
104
Novartis
NVS
$248B
| $165M | 0.18% |
2,036,698
+320,598
| +19% | +$25.9M |
|
105
Johnson & Johnson
JNJ
$429B
| $165M | 0.18% |
1,284,399
-2,185,401
| -63% | -$280M |
|
106
Mettler-Toledo International
MTD
$26.1B
| $163M | 0.18% |
284,300
+74,200
| +35% | +$42.7M |
|
107
EchoStar
SATS
$18.4B
| $162M | 0.18% |
3,067,680
+115,000
| +4% | +$6.07M |
|
|
ORBK
108
DELISTED
Orbotech Ltd
ORBK
| $162M | 0.18% |
2,601,900
-40,900
| -2% | -$2.54M |
|
109
Charles River Laboratories
CRL
$7.99B
| $156M | 0.17% |
1,460,300
+61,600
| +4% | +$6.58M |
|
110
Northrop Grumman
NOC
$83.2B
| $155M | 0.17% |
444,400
+101,900
| +30% | +$35.6M |
|
|
RTN
111
DELISTED
Raytheon Company
RTN
| $155M | 0.17% |
715,900
-216,500
| -23% | -$46.7M |
|
112
Edison International
EIX
$21.3B
| $154M | 0.17% |
2,426,300
-684,100
| -22% | -$43.5M |
|
113
BCE
BCE
$22.9B
| $154M | 0.17% |
3,581,771
+1,559,471
| +77% | +$67.1M |
|
114
Lockheed Martin
LMT
$105B
| $153M | 0.17% |
+451,600
| New | +$153M |
|
115
Keurig Dr Pepper
KDP
$39.5B
| $152M | 0.17% |
1,285,900
+563,600
| +78% | +$66.7M |
|
116
Motorola Solutions
MSI
$79B
| $150M | 0.16% |
1,424,415
+613,000
| +76% | +$64.5M |
|
117
National Grid
NGG
$68B
| $149M | 0.16% |
2,647,273
+267,045
| +11% | +$15.1M |
|
118
Franco-Nevada
FNV
$36.6B
| $149M | 0.16% |
2,183,900
+360,400
| +20% | +$24.6M |
|
119
Dominion Energy
D
$50.3B
| $148M | 0.16% |
+2,193,000
| New | +$148M |
|
120
Labcorp
LH
$22.8B
| $147M | 0.16% |
911,405
+161,306
| +22% | +$26.1M |
|
121
RenaissanceRe
RNR
$11.6B
| $146M | 0.16% |
1,053,815
+185,700
| +21% | +$25.7M |
|
122
Monster Beverage
MNST
$62B
| $145M | 0.16% |
2,540,700
+317,800
| +14% | +$18.2M |
|
123
National Beverage
FIZZ
$3.86B
| $145M | 0.16% |
1,630,900
+229,800
| +16% | +$20.5M |
|
124
Dolby
DLB
$6.94B
| $145M | 0.16% |
2,281,500
-49,800
| -2% | -$3.17M |
|
125
Jazz Pharmaceuticals
JAZZ
$7.99B
| $145M | 0.16% |
958,400
-286,400
| -23% | -$43.2M |
|